Multiple myeloma (MM) is a clonal B-cell malignancy, characterized by heterogeneity at both clinical and genomic level. Despite the role of specific cytogenetic aberrations in the pathogenesis of disease, the prognostic significance of cytogenetic changes has been identified in MM and it has become an integral part of disease management. The identification of high-risk and low-risk cytogenetic groups plays an important role in prediction of response or resistance to therapy. The cytogenetic findings are included in the consensus statement of the European Myeloma Network and International Myeloma Working Group [1] [2] [3] [4] [5] [6] [7] [8] . Traditional, conventional metaphase cytogenetics has shown limitations due to low proliferative nature of the malignant plasma cells which yield poor mitotic index. Several groups have adopted interphase fluorescence in situ hybridization (FISH) which could efficiently detect genetic changes such as chromosome 13 aberrations, del(17p), various IgH (immunoglobulin heavy chain) translocations and trisomies of the odd number of chromosomes in non-cycling plasma cells in >60 per cent of MM cases [1] [2] [3] [4] [6] [7] [8] . Large-scale, comprehensive cytogenetic data in MM are lacking in the Indian population. The present study was designed to evaluate the frequency of cytogenetic abnormalities, to analyze their clinico-pathological correlation and to implement the information in the risk stratification of disease.
Material & Methods
A total of 475 consecutive patients (male: 345, females: 130, age range: 25-90 yr) who were diagnosed in the department of Medical Oncology, Tata Memorial Hospital, Mumbai, India, between December 2009 and July 2012, were studied. Among these 475 patients, 50 were partially treated and were not in haematological remission. Diagnosis of MM was confirmed by bone marrow pathology and immunobiochemical parameters.
The study protocol was approved by the institutional ethics committee and a waiver to consent was granted.
Interphase FISH: Mononuclear cells from bone marrow aspirate were enriched by Ficoll Hypaque gradient centrifugation. Plasma cells were purified using CD138-coated magnetic beads according to the manufacturer's instructions (Miltenyi Biotec, Paris, France). Enriched plasma cells were identified by fluorescein isothiocyanate-conjugated anti-human kappa lambda light chain staining, and the purity was 95 per cent (range 70-99%).
Interphase FISH was performed on plasma cells using locus-specific probes, LSI 13 (17) 10 Stages I and II group were compared with Stage III. The occurrence of overall cytogenetic abnormalities as well as individual chromosomal abnormality such as Patients with t(4;14) had low haemoglobin (Hb) (P<0.001), low level of albumin (P<0.001), high ß2-microglobulin (P<0.001), high percentage of plasma cells (P<0.001) and Stage III disease (P<0.001) ( Table) . High level of ß2-microglobulin (P<0.016) with progressive disease (P<0.007) was observed in patients with del(17)(p13.1). Isolated group of hyperdiploidy was associated with low plasma cell index (P<0.004). Although higher age group was noted in all cytogenetic groups, it was significantly associated with t(14;16) (P<0.025) and hyperdiploid group (P<0.004) (Table) .
Results

Frequency of ∆13, del
Comparable differences were noted between aberrations positive group versus aberrations negative group. Aberrations positive group had low Hb (P<0.001), low albumin (P<0.001), high ß2-microblobulin (P<0.001), high index of plasma cells (P<0.001) and ISS Stage III (P<0.001).
Chromosome 1 aberrations:
In a group of 250 patients, 71 per cent (78/250) had chromosome aberrations and amp(1q) was seen in 83 of 250 (33%) patients. Although 1q21 probe was applied in all patients, 130 patients were also studied both by LSI 1q21 and LSI 1q25 probes, and the amplification at both 1q21 and 1q25 loci was detected with almost same clone size in positive cases (Fig. 1 ). An isolated amp(1q) was seen in only four per cent cases. On the contrary, amp(1q) was always noted in combination with other recurrent chromosome abnormalities. Of the 250 patients, 184 with proper clinical and laboratory details were enrolled for statistical analysis. A significant association of amp(1q) was seen in patients with t(4;14) (P < 0.03) and t(14;16) (P < 0.05). Clinico-pathological evaluation revealed association of t(4;14) with ∆13 and/or del(17) (p13.1) plus amp(1q) with high ß2-microglobulin (P<0.04), whereas sole ∆13 accompanied by amp(1q) had high ß2-microglobulin (P<0.05) and increased plasma cell index (P<0.002).
Discussion
In the present group of 475 MM patients, interphase FISH could detect recurrent genomic . Various cytogenetic subgroups such as hyperdiploidy, ∆13, del(17)(p13.1) IgH translocation subtypes t(11;14), t(4;14), t(14;16), t(8;14) and amp(1q) were identified. Overall frequencies of del(17)(p13.1) (9%), t(4;14) (10%), t(14;16) (3%), t(8;14) (1%) and hyperdiploidy (36%) were comparable to the reported studies, whereas frequencies of ∆13 (32%) and IgH translocations (27%) were low in comparison with reported studies 1, 2, 4, 5, [11] [12] [13] [14] . The occurrence of t(11;14) (5%) was significantly lower than t(4;14) (10%) in contrast to reported frequency (15-20% and 10-15%, respectively) 1, 15, 16 . The low frequency of t(11;14) lowered the frequency of IgH translocations. This could be due to geographic heterogeneity with ethnical differences. Greenberg et al 17 have reported overall low frequency of t(11;14) being 6.5 per cent in AfricanAmerican Blacks compared with Whites (17.6 %).
Fig. 2. (A) Dual colour IgH break apart probe on interphase cells shows normal IgH allele (yellow signal) and residual IgH (1 red signal and 1 green signal). (B) LSI IgH/CCND1 XT dual fusion probe on interphase cells shows dual fusion of IgH-CCND1 (1R1G2Y). (C) LSI IgH/ FGFR3 dual fusion probe on interphase cells shows one copy of FGFR3 (1 red signal), two copies of IgH (2 green signals) and 2-3 copies of IgH-FGFR3 (2-3 yellow signals). (D) LSI IgH/MAF dual fusion probe on interphase cells shows 1-2 copies of MAF (1-2 red signals), 1-2 copies of IgH (1-2 green signals) and 1-3 copies of fusion signals of IgH-MAF (1-3 yellow signals). (E) LSI IgH/MYC dual fusion probe on interphase cells shows normal allele of MYC (1 red signal), normal allele of IgH (1 green signal) and dual fusion signal of IgH-MYC (2 yellow signals).
Variant IgH translocations other than t(4;14) and t(14;16) are rare subtypes with a frequency of 2-5 per cent, and the targeted IgH loci are C-MYC at q24, CCND3 (Cyclin D3) at 6p21, IRF4 (Interferon regulatory factor 4) at 6p25, MAFB (Musculoaponeurotic fibrosarcoma oncogene homolog B) at 20q11 1, 4, 15, [18] [19] [20] . The prognostic significance of these IgH translocations is not clear due to lack of valid substantial data influencing clinical features and therapeutic response.
As evident from literature 1, 4, 5, 9, 11, 15, 21, 22 , IgH translocations, ∆13, del(17)(p13.1) were significantly associated with non-hyperdiploid group in our patients. Only a few patients with ∆13 showed heterozygous as well as homozygous deletion which indicated tumour heterogeneity. Association of ∆13/del(17)(p13.1) with t(4;14) in 475 patients and association of amp(1q) with t(4;14) and t(14;16) in the group of 250 patients indicated that del(17)(p13.1) and amp(1q) were progressive events in t(4;14) positive MM.
In a group of 392 patients with clinico-laboratory parameters in agreement with literature reports, hyperdiploid group was low-risk group [1] [2] [3] [4] 11, [21] [22] [23] . The various recurrent aberrations such as ∆13, TP53 deletion, IgH translocations and hyperdiploidy tended to occur in the old age group (>60 yr). Association of old age MM with higher rate of IgH translocations has been already reported by Butler et al 12 .
Various studies have revealed conflicting findings regarding the relationship of recurrent cytogenetic subtypes and their association with age 12, 24, 25 . Evaluation of clinico-pathological impact of various recurrent cytogenetic groups revealed association of t(4;14) and del(17)(p13.1) with highrisk features such as ß2-microglobulin, per cent plasma cells and advanced disease which confirmed that t(4;14) and del(17)(p13.1) were high-risk prognostic groups of MM. Translocation 4;14 and del(17)(p13.1) confer an adverse prognosis with shorter survival [1] [2] [3] [4] [5] 8, [18] [19] [20] 26, 27 . Sole, hyperdiploid MM was low-risk group. On the other hand, clustering of aggressive subtypes t(4;14) and del(17)(p13.1) in non-hyperdiploidy confirmed prognostic impact of ploidy and supported that hyperdiploidy and non-hyperdiploidy were the two major groups of MM 1, 4, 8, 9, 11 . Although 1q21 locus is a hot spot for amp(1q), yet several studies have also reported the involvement of 1q12-1q23. The amp(1q) seen in 250 patients revealed amplification at region 1q21 and 1q25. This indicates the importance of genes underlying the pathogenesis which are scattered in 1q12-1q25 region and not restricted to only 1q21 5, [28] [29] [30] [31] [32] . The copy number of 1q21 and median percentage of cells with amp(1q21) were found to have increased (more than three copies) in patients with advanced disease. Similar observation has been noted by Hanamura et al 28 . They found that relapsed patients with four copies of 1q21 at relapse had inferior post-relapse survival compared to those with three copies of 1q21.
Since amp(1q) always occurred in combination with other recurrent aberrations, it was difficult to assess its clinico-pathological impact as a sole or isolated abnormality; however, amp(1q) accompanied by t(4;14) and ∆13 and their association with highrisk features such as high ß2-microglobulin, increased plasma cell index, and advanced disease indicated its progressive role with genomic instability in myeloma pathogenesis. Wu et al 29 have also reported association of chromosome 1q aberration with ∆13 with adverse prognosis in patients on high-dose chemotherapy in MM. Though ∆13 was found to be low risk, its adverse prognostic implication could be due to its association with high-risk group such as t(4;14) and amp(1q).
In conclusion, the comprehensive cytogenetic data on MM patients by interphase FISH enabled identification of various prognostic subsets with risk stratification as a part of standard care. Low frequency of chromosome 13 aberrations and t (11;14) was an interesting observation, probably indicating ethnic diversity. Sole hyperdiploidy was a low-risk group, and clustering of aggressive subtypes t(4;14) and del (17) (p13.1) in non-hyperdiploid group confirmed that hyperdiploidy and non-hyperdiploidy were two major prognostic groups of MM. Amp(1q) accompanied by t(4;14) and ∆13 and their association with high-risk clinical and laboratory features focused on progressive role of amp(1q) in MM. Amp(1q) was clustered at 1q21 and also at 1q25 locus. Both interphase FISH with comprehensive profiling of various cytogenetic markers and selective molecular profiling may further improve classification and contribute in risk stratification of disease which should be adapted in standard routine care of MM patients in clinical practice.
Conflicts of Interest:
None.
